Publications by authors named "Mark L Levitt"

Claim this Profile
E
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO Requirements.
Fernando Carvalho Neuenschwander, Ofra Barnett-Griness, Stefania Piconi, Yasmin Maor, Eduardo Sprinz, Mark L Levitt

Microorganisms· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Antitumor Effect of the Serine Protease Urokinase Inhibitor Upamostat and the Sphingosine Kinase 2 Inhibitor Opaganib on Cholangiocarcinoma Patient-Derived Xenografts.
Faizal Z Asumda, Nellie A Campbell, Mohamed A Hassan, Reza Fathi, Daniella F Vasquez Rico, Mark L Levitt

Cancers (Basel)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.
Kevin L Winthrop, Alan W Skolnick, Adnan M Rafiq, Scott H Beegle, Julian Suszanski, Mark L Levitt

Open Forum Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Progress in the Development of Opaganib for the Treatment of Covid-19.
Charles D Smith, Lynn W Maines, Staci N Keller, Vered Katz Ben-Yair, Reza Fathi, Mark L Levitt

Drug Des Devel Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of paclitaxel + etoposide + cisplatin + concurrent radiation therapy for previously untreated limited stage small cell lung cancer (E2596): a trial of the Eastern Cooperative Oncology Group.
Leora Horn, Patricia Bernardo, Alan Sandler, Henry Wagner, Nathan Levitan, Mark L Levitt

J Thorac Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy and whole abdominal irradiation for gastric carcinoma.
Yulia Kundel, Mark L Levitt, Bernice Oberman, Siegal Sadezki, Thomas Tichler

Tumori· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors.
Yulia Kundel, Alon Yellin, Aron Popovtzer, Raphael Pfeffer, Zvi Symon, Mark L Levitt

Am J Clin Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib in recurrent glioblastoma.
M Raphael Pfeffer, Mark L Levitt, Dan Aderka

J Clin Oncol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of programmed cell death with an antisense Bcl-2 oligonucleotide.
Patrick P Koty, Wendong Lei, Mark L Levitt

Methods Mol Med· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of EGFR signal-transduction modulation by tyrosine kinase inhibitors to chemosensitivity and programmed cell death in lung cancer cell lines.
Wendong Lei, Patrick P Koty, Mark L Levitt

Methods Mol Med· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation of cells entering different programmed cell death pathways using a discontinuous Percoll gradient.
Patrick P Koty, Haifan Zhang, Wendong Lei, Mark L Levitt

Methods Mol Med· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo expression of p53 and Bcl-2 and their role in programmed cell death in premalignant and malignant lung lesions.
Patrick P Koty, Haifan Zhang, Wilbur A Franklin, Samuel A Yousem, Rodney Landreneau, Mark L Levitt

Lung Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceramide does not act as a general second messenger for ultraviolet-induced apoptosis.
Jiong Deng, Haifan Zhang, Freke Kloosterboer, Yong Liao, Jim Klostergaard, Mark L Levitt

Oncogene· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis